Mississippi SB2367 prohibits health insurance plans from requiring step therapy for prescription drugs treating advanced metastatic cancer.
Mississippi SB2367 amends existing law to prevent health insurance plans from mandating step therapy for prescription drugs used to treat advanced metastatic cancer. Step therapy requires patients to try and fail on other drugs before the insurer will cover the prescribed drug. The bill ensures that patients with advanced metastatic cancer can access necessary treatments without unnecessary delays. This change applies to drugs approved by the United States Food and Drug Administration and supported by evidence-based literature.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.